Objective-Perivascular adipose tissue (PVAT) contributes to vascular homeostasis by producing paracrine factors.
P erivascular adipose tissue (PVAT) is defined as adipose tissue surrounding the blood vessels. PVAT in rodents is similar to classical brown adipose tissue (BAT), 1 whereas human PVAT might be beige adipose tissue (BeAT). 2 BeAT, presenting characteristics of both white adipose tissue (WAT) and BAT, contains UCP-1 (uncoupling protein-1)-positive adipocytes. The intrinsic common characteristic of energy expenditure of both BAT and BeAT highlights their potential as targets in prevention of obesity and related cardiovascular diseases (CVDs). The roles of PVAT on atherosclerosis remain unclear. We previously reported that thermogenesis is one major physiological function of PVAT in response to cold stimuli 1 and that enhanced PVAT-dependent thermogenesis protects against atherosclerosis in mice. 3 Conversely, proinflammatory cytokines, such as IL (interleukin)-6, IL-8, and MCP-1 (monocyte chemoattractant protein-1), are significantly increased in PVAT of human coronary arteries of obese individuals when compared with other adipose depots. 4 A recent image-based study revealed a paracrine cross talk between PVAT and the rest of the underlying blood vessel layers in humans. 5 Recent clinical studies further support that PVAT is a source of various inflammatory mediators in CVDs, including coronary artery spasm, 6 metabolic syndrome, 7 and atherosclerosis. 8, 9 For example, in patients with coronary heart disease, the coronary PVAT showed higher expression of IL-1β, IL-6, and leptin compared with the PVAT of the internal thoracic artery devoid of atherosclerotic lesions. 10 Those changes were associated with reduced endothelial function, 11 suggesting that PVAT promotes atherosclerosis development through local production of inflammatory cytokines. Those data from clinical studies suggest that PVAT inflammation might contribute to atherosclerosis development.
We previously demonstrated enhanced atherosclerosis in a unique mouse model lacking PVAT as a result of deletion of the PPARγ (peroxisome proliferator-activated receptor γ) in vascular smooth muscle cells (VSMCs) driven by SM22α-knockin-Cre. 1 However, that model did not allow to distinguish whether the increased susceptibility to atherosclerosis was because of deletion of PPARγ in VSMCs or the ensuing lack of functional PVAT. More selective UCP-1-cre-driven brown (and beige) adipocyte-specific KO (knockout) models were developed to overcome those hurdles and allowed us to dissect the roles in PVAT of specific genes relevant to CVD. 12 In this study, we used newly generated BA-PPARγ-KO (brown adipocyte-specific PPARγ KO) mice to address the specific contribution of PVAT to atherosclerosis development. PPARγ ablation in brown adipocytes dramatically inhibited development of PVAT and interscapular BAT (iBAT) without affecting WAT development or PPARγ expression in VSMCs. Using this new model, we demonstrated that loss of functional PVAT promotes macrophage infiltration to the periphery of the blood vessels and increases atherosclerosis development, suggesting a causative role for PVAT in atherosclerosis.
Materials and Methods
The data and materials have been made publicly available from the corresponding author on reasonable request. The authors declare that all supporting data are available within the article and its online-only Data Supplement. Details for major experimental resources can be found in the Table I in the online-only Data Supplement.
Animal Procedures
BA-PPARγ-KO mice were generated by crossbreeding PPARγ flox/flox with UCP-1-driven Cre mice 13 (all in the C57BL/6 background). Mice were housed at the University of Michigan animal facility (22°C and 12/12-hour light/dark cycle) and supplied with rodent diet No. 2918 (18% protein, 6% fat, and moderate phytoestrogen; Harlan Laboratories) ad libitum. The Animal Research Ethics Committee of the University of Michigan approved the study protocol. iBAT temperature was monitored by a T-type thermocouple probe inserted into the iBAT in mice under anesthesia (isoflurane inhalation) in response to immersion of the tail and hind paws in a 4°C water bath, as described before. 1 For surgical removal of the iBAT, mice were anesthetized by isoflurane inhalation, and the procedure was performed as described previously. 1 Briefly, after removal of the subscapular hair, a 1-cm-long incision along the midline skin was made to expose the iBAT, which was completely removed from the interscapular trigonal pyramidal region using an electric cauterizer. This procedure permanently destroys the remaining brown adipocytes and prevents BAT from growing back ( Figure II in the online-only Data Supplement). Subcutaneous injection of 0.1 mg/kg buprenorphine for 3 consecutive days was used as analgesic. To study atherosclerosis, BA-PPARγ-KO mice were crossed with ApoE (apolipoprotein E) KO mice to generate the DKO (double KO; ApoE/BA-PPARγ DKO). The offspring were genotyped by polymerase chain reaction analysis of DNA obtained from tail-snip biopsies using specific primers. We selected 2 groups of mice for this study: (1) ApoE KO and (2) ApoE/BA-PPARγ DKO mice. All experiments were conducted using 8-week-old male or female mice, and the numbers used are indicated in the corresponding figure legends. We present data from male mice in the main figures. When female mice were used in the online-only Data Supplement, that is specified in the legend. For the atherosclerosis study, the mice were fed a high-cholesterol diet (Harlan, TD.88137) for 2 or 3 months. At the end point, the mice were euthanized by CO 2 inhalation. The plasma was preserved at −80°C for cytokine analysis and plasma lipid and lipoprotein profiling. 1 Oil Red O staining was used for en face analysis of atherosclerotic plaques in the aortic trees. 1 After removal of the perivascular tissue, the aortas were opened longitudinally and pinned flat onto a wax plate. The percentage of the plaque area in the thoracic (including aortic arch) and abdominal aorta relative to the thoracic or abdominal luminal surface areas was calculated by an image software (Meta Imaging Series 7.0; Molecular Devices, LLC). The extent of atherosclerotic lesions in the aortic sinus region was determined following the guidelines for experimental atherosclerosis studies described in the American Heart Association Statement. 14 The atherosclerotic lesion area at the 3 valve leaflets was quantified by using National Institutes of Health ImageJ analysis software. All morphometric analyses were performed in a double-blinded manner.
Isolation of Leukocytes From PVAT and Flow Cytometry Analysis
Dissection of PVAT and subsequent recovery of leukocytes was achieved by collagenase digestion following a well-established protocol. 15 Factors such as the duration of collagenase exposure were determined empirically and restricted to ≤45 minutes. Isolated cells were additionally incubated with ACK lysing buffer (154.4 mmol/L ammonium chloride, 10 mmol/L potassium bicarbonate, and 97.3 μM EDTA) for 15 minutes to lyse the remaining red blood cells in PVAT. Leukocyte numbers and differential counts were performed using flow cytometry analysis as described previously. 16 Isolated PVAT leukocytes were incubated with anti-mouse CD (cluster of differentiation) 16 Figure III 
Lipoprotein and Lipid Analysis
Plasma lipoprotein profiles were determined by fast-performance liquid chromatography as described previously. 17 Briefly, 80 μl of plasma were loaded and eluted at a constant flow rate of 0.5 mL/ min. Thirty fractions per sample were collected. Sample elution was monitored by optical density at 280 nm. The cholesterol contents in each fraction were measured with a cholesterol fluorometric assay kit (cat No. 10007640; Cayman Chemical). For liver lipid analysis, the livers were rapidly removed from the euthanized mice and kept at −80°C. The frozen liver samples (≈100 mg) were homogenized in PBS and the homogenates were then centrifuged (14 000 revolutions per minute, 20 minutes). The supernatants were collected and analyzed for protein levels using the Bio-Rad Bradford assay (Hercules, CA). To assess the liver lipid composition, lipids were extracted from the supernatants with hexane:isopropanol (3:2, v:v; Sigma Aldrich, St. Louis, MO), and the hexane phase was allowed to evaporate for 48 hours. Spectrophotometric determination of the amounts of liver cholesterol or triglycerides was performed using commercially available kits (Wako Chemicals, Japan). Data were normalized to protein levels and are presented as microgram cholesterol or triglycerides per milligram protein. 18 Plasma total cholesterol and triglycerides were determined using the same kits (Wako Chemicals, Japan).
Quantitative Real-Time Polymerase Chain Reaction and Western Blot Analysis
Total RNA was isolated from the adipose tissues using TRIzol reagents (Invitrogen). The mRNA levels were measured by quantitative real-time polymerase chain reaction using a Bio-Rad thermocycler and a SYBR green kit (Bio-Rad). 3 Western blot analyses were performed as described previously.
3 Rabbit anti-UCP-1 (0.5 μg/mL, cat No. U6382; Sigma), rabbit anti-PRDM16 (PR/SET domain 16; 0.2 μg/mL, cat No. AF6295; R&D), and anti-PPARγ (0.8 μg/mL, cat No. sc-7196; Santa Cruz) were used in this study. Mouse primers and antibodies used in this study are listed in the Table I in the online-only Data Supplement.
Histological Analysis
Adipose tissues were fixed overnight with 4% paraformaldehyde (pH 8.0). After dehydration, the samples were embedded in paraffin wax according to standard laboratory procedures. Sections of 5 µm were stained with hemotoxylin and eosin or the macrophage marker F4/80 (2.5 μg/mL, clone CI:A3-1; Bio-Rad).
Statistical Analysis
GraphPad Prism software, version 7.0, was used to analyze the data. Data are shown as mean±SD or column box and whiskers plot. The data were first analyzed for normal distribution and then evaluated with a 2-tailed, unpaired Student t test between 2 groups or 1-way ANOVA followed by a Newman-Keuls test or 2-way ANOVA and multiple comparisons for repeated measures. A value of P<0.05 was considered statistically significant.
Results

Brown Adipocyte-Specific PPARγ Deletion Results in Impaired Development of PVAT and iBAT
Prior studies indicated that the thoracic PVAT in mice is almost identical to iBAT. 1, 19 Therefore, we used brown adipocyte-specific UCP-1-Cre to delete PPARγ in brown adipocytes. As shown in Figure 1A , PPARγ protein is detectable in PVAT, WAT, and iBAT of wild-type mice. In the BA-PPARγ KO mice, PPARγ is undetectable in PVAT and iBAT without changes in expression in subcutaneous WAT (sWAT) or in the aorta stripped from PVAT, where the levels are intrinsically lower. Deletion of PPARγ in brown adipocytes did not affect PPARα and PPARδ expression ( Figure 1B ). Because Ucp-1 is not expressed in white adipocytes, PPARγ mRNA levels in sWAT and gonadal WAT (gWAT) were comparable between wild-type and BA-PPARγ KO mice ( Figure IA in the onlineonly Data Supplement), in spite of sWAT being recognized as a BeAT with a small fraction of UCP-1-positive cells on cold stimuli. 2 Because PPARγ is a key transcription factor controlling adipocyte differentiation, brown adipocyte differentiation in thoracic PVAT and iBAT in the BA-PPARγ KO mice was significantly inhibited. Compared with the wild-type mice, only remnants of PVAT or iBAT were found in the thoracic aorta and interscapular regions, respectively ( Figure 1C) . Specifically, only a thin layer of tissue comprised of cells morphologically distinct from adipocyte remains surrounding the artery. Indeed, hemotoxylin and eosin staining of sections of thoracic PVAT or iBAT uncovered absence of normal classical brown adipocytes characterized by small and multilocular lipid droplets. Instead fibrous-like tissues with large numbers of nonadipocytes are observed in PVAT and iBAT ( Figure 1D) . Consistently, the mRNA levels of the adipocyte marker genes Fabp4 and adiponectin were significantly reduced, whereas the lipolysis genes LPL and ATGL were not significantly altered in PVAT and iBAT of BA-PPARγ-KO mice (Figure 2) , probably reflecting preservation of the white adipocyte fraction normally present in BAT. Additionally, because PPARγ expression is preserved in WAT of BA-PPARγ-KO mice, the WAT appears normal (Figure IB in the online-only Data Supplement), and consequently, the expression of adipocyte marker genes and lipolysis genes was comparable in subcutaneous and gWAT between wild-type and BA-PPARγ-KO mice ( Figure 2 ).
Brown Adipocyte-Specific PPARγ Deletion Results in Impaired Thermogenesis in BAT
Next, we determined the mRNA levels of thermogenic genes in PVAT and iBAT of BA-PPARγ-KO mice. When compared with wild-type mice, thermogenic genes, such as UCP-1, Cidea, Cox8b, Elovl3, and Otop1, were significantly downregulated in PVAT and iBAT in the BA-PPARγ-KO mice ( Figure 3A) . However, those genes are increased in subcutaneous and gWAT, likely as a compensatory mechanism. Prdm16-a brown adipocyte determinant-was downregulated in PVAT, iBAT, and sWAT but was not changed in gWAT. Dio2 is traditionally thought to be a thermogenic gene. However, Dio2 mRNA level is increased only in the iBAT but not in the PVAT, sWAT, and gWAT of the BA-PPARγ-KO mice. Other beige adipocyte markers, such as Ebf2 (early B cell factor 2), Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain (Cited), and Tbp (TATA boxbinding protein), remained unchanged in all adipose tissues ( Figure 3A) . Consistent with reduced expression of thermogenic genes in iBAT, the UCP-1 and PRDM16 proteins were significantly reduced in iBAT of BA-PPARγ-KO mice as well ( Figure 3B ). We determined the temperature changes in the BAT region by cold stimulation of the hind paws and tail. 1, 3 In response to acute cold stimuli, the temperature in iBAT of wild-type mice was immediately increased-an indication of heat production in BAT. 1 The temperature in the iBAT region of BA-PPARγ-KO mice was increased by 29.76±12.2% of the wild-type levels at the end point, being significantly lower that wild-type throughout the 90 seconds of the acute cold stimuli, indicating impaired thermogenesis in the mice lacking functional BAT ( Figure 3C ). These data demonstrate that deletion of PPARγ in brown adipocytes leads to lack of functional PVAT and BAT development.
Brown Adipocyte-Specific PPARγ Deletion Results in Increased Local Inflammation
We further addressed inflammation in PVAT and iBAT of BA-PPARγ-KO mice. As shown in Figure 4A , the mRNA levels of IL-1β, MCP-1, and TNFα (tumor necrosis factor-α) were significantly increased in PVAT and iBAT of BA-PPARγ-KO mice when compared with those of wildtype mice, while remaining unaltered in subcutaneous and gWAT. Immunohistochemical staining for the macrophage marker F4/80 indicated that macrophage infiltration was significantly increased in both thoracic PVAT and iBAT of BA-PPARγ-KO mice, with no significant differences in subcutaneous and gWAT between wild-type and BA-PPARγ-KO mice ( Figure 4B ). These results indicate that deletion of PPARγ in brown adipocytes, which efficiently blocked brown adipocyte differentiation, results in infiltration of macrophage and higher basal inflammation in the PVAT and iBAT regions while showing no effects in WAT.
Brown Adipocyte-Specific PPARγ Deletion Results in Increased Atherosclerosis Development
To investigate the pathophysiological consequences of lack of PVAT on atherosclerosis, the BA-PPARγ-KO mice were crossbred with ApoE KO mice to generate the DKO mice. To exclude any potential effects of iBAT on atherosclerosis development, the iBAT in ApoE KO mice and its remnants in the ApoE/BA-PPARγ DKO mice were surgically removed from 7-week-old mice. After 1-week of recovery, the mice were fed a high-cholesterol diet for 3 months. As shown in Figure 5A and Figure III in the online-only Data Supplement, the atherosclerotic lesions were significantly greater in both male and female ApoE/BA-PPARγ DKO than that in the corresponding ApoE KO control mice (male: 29.3±5.9% versus 19.8±4.2% in thoracic aorta and 6.7±2.1% versus 2.2±1.6% in abdominal aorta; female: 25.8±7.6% versus 16.4±4.2% in thoracic aorta and 10.1±3.5% versus 2.3±1.7% in abdominal aorta). The area of atherosclerotic lesions in the aortic root region in ApoE/BA-PPARγ DKO mice was ≈70% higher than that of ApoE KO mice ( Figure 5B ). The increase in body weight was comparable between the 2 groups, independent of sex (data not shown). Analysis of plasma lipoprotein profiles indicated that the very low-density lipoprotein and low-density lipoprotein fractions, but not high-density lipoprotein, were elevated in the ApoE/BA-PPARγ DKO ( Figure 5C ), likely as a result of increased production of cholesterol and triglycerides in the liver ( Figure IVA and IVB in the online-only Data Supplement). Unlike WAT, mostly involved in lipid storage, BAT contributes to the clearance of plasma lipids and protects against atherosclerosis development. 20 Surgical removal of iBAT in ApoE KO mice significantly increased plasma total cholesterol and triglyceride levels. However, total cholesterol levels were still relatively higher in the plasma in ApoE/ BA-PPARγ DKO without iBAT ( Figure VA in the onlineonly Data Supplement). Additionally, it is possible that BAT removal in ApoE KO mice could promote WAT browning. However, expression of thermogenesis genes, such as Ucp-1, Cox8b, and Pgc1α, in WAT was comparable between the ApoE KO (with iBAT removal) and ApoE/BA-PPARγ DKO mice when the mice were housed in a 22°C environment for 2 months. Also, the body temperature of these mice was comparable ( Figure VB and VC in the online-only Data Supplement).
Notably, when considering the suprarenal abdominal aortic area, almost all of the ApoE/BA-PPARγ DKO mice showed atherosclerotic lesions. However, there were only sporadic atherosclerotic lesions observed in ApoE KO mice in that region. According to the guidelines for experimental atherosclerosis studies described in the American Heart Association Statement, measurement of the surface area of atherosclerotic lesions only provides a 2-dimensional surface area without taking into account the thickness of lesions.
14 As shown in Figure 6A , the cross sections confirmed the existence of more advanced atherosclerotic lesions in thoracic and suprarenal abdominal aorta from the ApoE/BA-PPARγ DKO mice compared with the ApoE KO mice. Consistent with the increased macrophage infiltration observed in PVAT of the BA-PPARγ KO mice (Figure 4) , we found increased F4/80-positive macrophages in PVAT of plaque areas, both thoracic and abdominal, in the ApoE/BA-PPARγ DKO mice compared with the ApoE KO mice ( Figure 6A ). To investigate whether the PVAT of ApoE/BA-PPARγ DKO was inflammatory, the immune cells present in PVAT were characterized by FACS ( Figure  VI Figure 6B ). The mRNA levels ( Figure 6C ) of IL-6, TNFα, and MCP-1 in the remnants of PVAT of ApoE/BA-PPARγ DKO mice compared with PVAT of ApoE KO mice were increased as were the corresponding cytokines in the conditioned medium of the same cells in vitro ( Figure 6D ). Abdominal PVAT is beige fat, which is a mixture of WAT and BAT. However, similar to the thoracic PVAT, the brown adipocyte markers were reduced, whereas the inflammatory markers MCP-1 and TNFα were increased in abdominal PVAT of ApoE/BA-PPARγ DKO mice ( Figure 6E ), suggesting that loss of brown adipocytes in abdominal PVAT was also associated with PVAT inflammation. Thus, these data clearly demonstrate that lack of PVAT development resulted in perivascular inflammation and enhanced the atherosclerosis development.
Discussion
The appearance and physiological role of adipose tissue may vary depending on anatomic and metabolic context. The most popular classification of adipose tissues refers to their coloration, that is, WAT and BAT. The principal function of WAT is to store energy as triglycerides. In contrast, BAT uses triglycerides as fuel for heat production. Adipose tissues are also classified for their specific locations, for example, pericardial adipose tissue (around the heart), perirenal adipose tissue (around the kidneys), and PVAT (around the blood vessels). The color of these specific depots is either WAT or BAT. Rodents have BAT surrounding thoracic blood vessels (referred to as PVAT) throughout their whole life, whereas humans are born with BAT surrounding large blood vessels of the thorax that is subsequently replaced by WAT in adults. 21 Recent studies that uncovered a browning phenotype in WAT 2 suggest the the BAT surrounding the large blood vessels is not replaced by WAT but undergoes whitening in the adult human, which might thus represent BeAT. 2 The BeAT is defined as clusters of brown-like adipocytes in WAT. Indeed, a subpopulation of the stromal vascular population (Sca1 + CD45 − Mac1 − ) resident in WAT can differentiate into UCP-1 expressing beige adipocytes. 22 It is well-established that visceral fat is toxic and secrets inflammatory cytokines/adipokines, which might promote the development of CVDs. Because beige adipocytes can burn lipids like classical brown adipocytes, therapeutic strategies aimed at WAT browning are intensely pursued for the treatment of diabetes mellitus and CVDs. 23 PPARγ is a central regulator of adipocyte gene expression and differentiation. 24 PPARγ global deficiency in mice leads to embryo lethality, which on rescue results in lipodistrophy. 25, 26 Adipocyte-specific deletion of PPARγ results in marked adipocyte hypoplasia and hypertrophy 27 with abnormalities in the formation and function of both BAT and WAT. 28 The present study further demonstrates that PPARγ deletion in brown adipocytes results in abnormalities in BAT development and function of both iBAT and aortic PVAT. In spite of the relatively long distance from visceral fat depots to cardiovascular target organs, the endocrine cytokines/adipokines from visceral fat were considered the major contributors to the development of CVDs. 29 Recent studies suggest that paracrine factors from local adipose tissues, that is, PVAT and pericardial adipose tissues, may be more directly associated with the development of CVDs. 1, 9, 12, 30 It was reported that BAT contributes to clearance of plasma lipids and protects against atherosclerosis development. 20 However, it is unclear whether the lipotoxicity in the aorta during atherosclerosis development is caused by the adjacent PVAT. Our previous study documented that lack of PVAT, concomitant to deletion of PPARγ in VSMCs, might be associated with enhancement of atherosclerosis. 1 However, because of the concurrent PPARγ deficiency in VSMCs, that model did not allow to distinguish between the individual roles of PVAT and VSMCs on atherosclerosis even though the PVAT was completely missing. 1 In this study, the BA-PPARγ-KO mice show depletion of PVAT without affecting PPARγ expression in VSMCs. Even though this model is still not optimal to study the roles of PVAT because of the concurrent disruption of iBAT, to date, this is the best mouse model to study PVAT function when combined with surgical removal of iBAT. We acknowledge that there are some remaining limitations in our ability to define PVAT roles. First, there are multiple BAT depots, apart from iBAT and PVAT, including deep neck and perirenal areas. However, iBAT is the major depot of BAT and the only BAT amenable to surgical removal. Removal of the BAT in other depots is currently unfeasible and impractical. Second, cold-induced thermogenesis in BAT promotes plasma lipid clearance. In such situation, loss of BAT leads to compensatory thermogenesis in WAT, likely underlying the observed changes in gene expression of WAT from BA-PPARγ KO mice ( Figure 3A) , even when the mice were housed at 22°C. Therefore, loss of thermogenesis in BAT because of the surgical removal of BAT in the ApoE KO mice might affect the compensatory thermogenesis in WAT as well, which could have a significant impact on WAT biology and thermogenic function. Nonetheless, expression of thermogenesis genes (eg, Ucp-1, Cox8b, and Pgc1α, in Figure VB in the online-only Data Supplement) were comparable in the WAT of the ApoE KO and ApoE/BA-PPARγ DKO mice, indicating that the iBAT removal in the ApoE KO mice functionally mimics the iBAT-hypoplastic effects resulting from the genetic ablation of BA-PPARγ in the DKO mice. Thus, using this new BA-PPARγ-KO model in the ApoE KO background, we demonstrated that atrophy of PVAT results in significant increase in atherosclerotic lesion, thus suggesting that lack of functional PVAT drives increased atherosclerosis. This phenotype is reminiscent of that in the ApoE KO mice with insulin receptor deficiency in brown adipocytes, which also showed severe brown fat lipoatrophy and aggravated atherosclerosis. 31 Inflammatory changes in the arterial wall play crucial roles in promoting atherosclerosis development. PVAT-resident and recruited inflammatory cells have been hypothesized to be responsible for vascular diseases. 32 Additionally, accumulation of inflammatory cells in the PVAT of human atherosclerotic aortas indicates that PVAT recruits proinflammatory cells during atherogenesis and is primed for inflammatory responses. 33 A postmortem study showed that atherosclerotic plaque-to-media ratio increased with increasing PVAT area and PVAT macrophage infiltration. Furthermore, PVAT macrophage infiltration positively correlates with adventitia and plaque macrophages. 30 Recent data from animal studies indicate that augmenting PVAT-specific inflammation exaggerates atherosclerosis. For example, delivery of miR19b to carotid PVAT promoted secretion of inflammatory cytokines and infiltration of macrophages in PVAT and enhanced atherosclerosis. However, loss of PVAT attenuated miR19b-mediated atherosclerosis development and inflammatory cytokines in the plaque. 8 Conversely, transplant of TLR4-deficient bone marrow resulted in fewer atherosclerotic lesions in low-density lipoprotein receptor-deficient mice, which was associated with increased browning of PVAT and decreased TNFα expression in PVAT, 34 arguing that PVAT inflammation directly correlates with the severity of atherosclerosis. Brown adipocyte-specific deletion of PPARγ here not only resulted in inhibition of BAT development but also increased basal macrophage infiltration in iBAT and PVAT. Furthermore, the inflammatory cytokines, such as TNFα, MCP-1, and IL-6, were increased in PVAT of ApoE/BA-PPARγ DKO mice. Additionally, our studies indicated that total cholesterol and triglyceride levels in the liver and plasma were higher in mice with malformation of PVAT, suggesting an abnormal lipid metabolism in this model.
A major function of BAT is to produce heat, and it was hypothesized that enhanced thermogenesis in PVAT would protect against obesity-associated atherosclerosis development. Indeed, increased BAT thermogenic activity drastically accelerates clearance of plasma triglycerides as a result of increased uptake into BATs, and BAT activity controls vascular lipoprotein homeostasis by inducing a metabolic program that boosts triglyceride-rich lipoprotein turnover and channels lipids into BAT. 35 Our study indicated that basal thermogenesis is impaired in the BA-PPARγ-KO mice. Additionally, plasma total cholesterol and triglycerides were increased in the DKO mice (with iBAT removal), suggesting that the PVAT may contribute to enhance total cholesterol and triglyceride clearance from circulation. This phenomenon might also be caused by generation of more cholesterol and triglycerides in the liver of the DKO mice as evidenced by increased cholesterol and triglyceride levels in liver of ApoE/BA-PPARγ DKO mice fed a chow diet. This novel model of PPARγ deletion in brown adipocytes will allow us to extend these studies to address the specific contributions of PVAT to lipid clearance and any potential metabolic signaling to the liver.
In summary, the results of this study demonstrate that deletion of PPARγ in brown adipocytes impairs PVAT development, without affecting PPARγ expression in smooth muscle cells. Of significance, we show that lack of PVAT development leads to increased local inflammation, which further promotes atherosclerosis development. These findings reinforce the notion of a beneficial impact of a functional PVAT in the protection against atherosclerosis and indicate that preserving PVAT function may, therefore, represent a new therapeutic target for atherosclerosis and other CVDs.
